HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO., LTD.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 06, 2018 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 16 Total Citation Count
- Jun 06, 2014 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9884856 Crystal form of Dabrafenib mesylate and preparation method thereofAug 25, 16Feb 06, 18[A61K, C07D]
9708301 Crystalline forms of afatinib monomaleate, preparation methods and pharmaceutical compositions thereofJan 14, 16Jul 18, 17[A61K, C07D, C07C]
9562024 Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usageFeb 19, 16Feb 07, 17[C07D]
9458149 Crystal form of dabrafenib and preparation method and use thereofMar 25, 16Oct 04, 16[C07D, C30B]
9453011 Crystal form of dabrafenib mesylate and preparation method thereofOct 28, 15Sep 27, 16[A61K, C07D]
9181243 Solvate form M of trametinib dimethyl sulfoxide and methods of making and using thereofJun 30, 14Nov 10, 15[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0200,698 VORTIOXETINE SALT AND CRYSTAL THEREOF, THEIR PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND USAGEAbandonedJun 06, 14Jul 14, 16[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.